| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000046681 |
| Receipt No. | R000053133 |
| Scientific Title | Study of ingestion of protein powder |
| Date of disclosure of the study information | 2022/01/20 |
| Last modified on | 2022/07/25 (Ver. 2) |
| Basic information | ||
| Public title | Study of ingestion of protein powder | |
| Acronym | Study of ingestion of protein powder | |
| Scientific Title | Study of ingestion of protein powder | |
| Scientific Title:Acronym | Study of ingestion of protein powder | |
| Region |
|
|
| Condition | ||
| Condition | None | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Effect of test food on the body |
| Basic objectives2 | Others |
| Basic objectives -Others | Absorption kinetics after food ingestion |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Plasma amino acids, BAP, d-ROMs, testosterone, glucose and irisin concentration and questionnaire |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Ingestion of test food (1 week) | |
| Interventions/Control_2 | Ingestion of placebo food (1 week) | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | Male students belonging to University of Tsukuba who are healthy and not suffered from a chronic malady.
Individuals whose written informed consent has been obtained. |
|||
| Key exclusion criteria | Individuals who have possibility of allergy symptoms onset by the test food and who cause allergic symptoms in foods and medicines.
Individuals who are a smoker. Individuals who have a habit to ingest food containing test food ingredients on a daily basis. |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | University of Tsukuba | ||||||
| Division name | Faculty of Health and Sport Sciences | ||||||
| Zip code | 305-8574 | ||||||
| Address | 1-1-1, Tennou dai, Tsukuba city | ||||||
| TEL | 029-853-6319 | ||||||
| omi.naomi.gn@u.tsukuba.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | University of Tsukuba | ||||||
| Division name | Faculty of Health and Sport Sciences | ||||||
| Zip code | 305-8574 | ||||||
| Address | 1-1-1, Tennou dai, Tsukuba city | ||||||
| TEL | 029-853-6319 | ||||||
| Homepage URL | |||||||
| omi.naomi.gn@u.tsukuba.ac.jp | |||||||
| Sponsor | |
| Institute | University of Tsukuba |
| Institute | |
| Department | |
| Funding Source | |
| Organization | MORINAGA & CO., LTD. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Research ethics committee,Faculty of Health and Sport Sciences,University of Tsukuba |
| Address | 1-1-1 Tennodai, Tsukuba,Ibaraki |
| Tel | 029-853-2571 |
| tg-kenkyurinri@un.tsukuba.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053133 |